Evidence map›Paper›PMID 35814387›Full record

ArticleFrontiers in oncology2022

Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.

Zhaoxia Zhang, Chenghao Zhanghuang, Jinkui Wang, Xiaomao Tian, Xin Wu, Maoxian Li, Tao Mi, Jiayan Liu, Liming Jin, Mujie Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhaoxia ZhangDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Chenghao ZhanghuangDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Jinkui WangDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Xiaomao TianDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Xin WuDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Maoxian LiDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Tao MiDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Jiayan LiuDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Liming JinDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Mujie LiDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Dawei HeDepartment of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, China.
Chongqing Medical University · CNChildren's Hospital of Chongqing Medical University · CNChina International Science and Technology Cooperation · CNKunming Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Prostate cancer (PC) is the most common non-cutaneous malignancy in men worldwide. Accurate predicting the survival of elderly PC patients can help reduce mortality in patients. We aimed to construct nomograms to predict cancer-specific survival (CSS) and overall survival (OS) in elderly PC patients. Methods: Information on PC patients aged 65 years and older was downloaded from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox regression models were used to determine independent risk factors for PC patients. Nomograms were developed to predict the CSS and OS of elderly PC patients based on a multivariate Cox regression model. The accuracy and discrimination of the prediction model were tested by the consistency index (C-index), the area under the subject operating characteristic curve (AUC), and the calibration curve. Decision curve analysis (DCA) was used to test the clinical value of the nomograms compared with the TNM staging system and D'Amico risk stratification system. Results: 135183 elderly PC patients in 2010-2018 were included. All patients were randomly assigned to the training set (N=94764) and the validation set (N=40419). Univariate and multivariate Cox regression model analysis revealed that age, race, marriage, histological grade, TNM stage, surgery, chemotherapy, radiotherapy, biopsy Gleason score (GS), and prostate-specific antigen (PSA) were independent risk factors for predicting CSS and OS in elderly patients with PC. The C-index of the training set and the validation set for predicting CSS was 0.883(95%CI:0.877-0.889) and 0.887(95%CI:0.877-0.897), respectively. The C-index of the training set and the validation set for predicting OS was 0.77(95%CI:0.766-0.774)and 0.767(95%CI:0.759-0.775), respectively. It showed that the proposed model has excellent discriminative ability. The AUC and the calibration curves also showed good accuracy and discriminability. The DCA showed that the nomograms for CSS and OS have good clinical potential value. Conclusions: We developed new nomograms to predict CSS and OS in elderly PC patients. The models have been internally validated with good accuracy and reliability and can help doctors and patients to make better clinical decisions.

Indexed as

CSSnomogramold ageprostate cancerSEER

Identifiers

PMID35814387
PMCPMC9259789
OpenAlexW4283331268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.